Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Gencurix's study explores GenesWell BCT and Oncotype DX differences

biospectrumasiaAugust 25, 2019

Tag: Mi Jeong Kwon , Gencurix , GenesWell BCT

PharmaSources Customer Service